Loading...

SBFM SUNSHINE BIOPHARMA INC Capital Structure Changes 8-K Filing

SNSH

SBFM

SUNSHINE BIOPHARMA INC

(SBFM)

2024 8-K

Annual Meeting Results

Accounting Firm Change

Financial Statements

Securities Offering

Financial Results

Management Appointment

Annual Meeting Results

Financial Results

Management Changes

Financial Results

Exception Granted by Nasdaq

Financial Results Announcement

Appointment of Accountant

Accountant Change

Amendment to Articles of In...

Financial Results Announcement

Agreement and Reverse Stock...

Approval of Alternative Cas...

Public Offering

Buyback of Warrants

Management Appointments

Annual Meeting of Stockholders

Financial Results Announcement

Termination of Research Agr...

Amendment to Warrant Agent ...

Meeting Amendment

Notification of Non-Complia...

Earnings Reports

Private Placement

Financial Results Announcement

Amendment to Bylaws

Agreement with University o...

Compliance Regained

Research Agreement

External Links:

Sunshine Biopharma, Inc. agreed to sell 100,000 shares of Series B Preferred Stock to its CEO for $10,000 and approved a reverse stock split to regain compliance with Nasdaq rules.

AI Assistant

SUNSHINE BIOPHARMA INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.